Therefore, our study focuses on the period 2021–2023 and examines three types of screening available through the public system: bilateral screening mammography, fecal occult blood test, and prostate-specific antigen, which address the cancers with the highest burden in the Peruvian population. This evidence concerns the gene KLK3 and cancer.